RE-ELECT. Dabigatran vs Warfarin in AF Patients With T2DM and CKD
Status:
Recruiting
Trial end date:
2022-05-01
Target enrollment:
Participant gender:
Summary
Kidney function in patients with atrial fibrillation (AF) is tending to decline over a time
which is clearly demonstrated in clinical studies. Renal impairment is a risk factor for
stroke, its progression is associated with unfavorable prognosis. So preserving kidney
function should be considered as a one of priorities when choosing treatment strategies which
is especially important in patients with existing chronic kidney disease (CKD) or in patients
who have risk of its development. This is especially relevant for the patients with type 2
diabetes mellitus (T2DM) and with CKD who can be considered as a group of risk for rapid
kidney function decline.